Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 11/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | XDH | P47989 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21882451 | 1.00 | MCL1 (0.69) | MCL1MAPK1TDP1CYP19A1RAB9A | |
| SCHEMBL13203160 | 1.00 | MCL1 (0.69) | MCL1MAPK1TDP1CYP19A1RAB9A | |
| SCHEMBL14801814 | 0.98 | MCL1 (0.71) | MCL1MAPK1TDP1CYP19A1RAB9A | |
| SCHEMBL21882444 | 0.93 | MCL1 (0.61) | MCL1MAPK1TDP1XDHMEN1 | |
| SCHEMBL21882441 | 0.93 | MCL1 (0.61) | MCL1MAPK1TDP1XDHMEN1 | |
| SCHEMBL21882466 | 0.93 | MCL1 (0.61) | MCL1MAPK1TDP1CYP19A1RAB9A | |
| SCHEMBL21882452 | 0.93 | MCL1 (0.61) | MCL1MAPK1TDP1XDHMEN1 | |
| SCHEMBL21882399 | 0.93 | MCL1 (0.61) | MCL1MAPK1TDP1XDHMEN1 | |
| SCHEMBL20220124 | 0.93 | MCL1 (0.61) | MCL1MAPK1TDP1CYP19A1RAB9A | |
| SCHEMBL29169589 | 0.91 | MCL1 (0.60) | MCL1TDP1RAB9ANPC1XDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11730009-B2 | Compound and organic light-emitting element comprising same | LG CHEM, LTD. | 2023-08-15 | — | — | US | disclosed |
| EP-3330265-B1 | COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2020-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11730009-B2 | Compound and organic light-emitting element comprising same | CRY2, CRY1, NR2E3 | MCL1 1847/4885MAPK1 4091/4885TDP1 3773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.